Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department
Authors
Keywords
-
Journal
EUROPACE
Volume -, Issue -, Pages euw052
Publisher
Oxford University Press (OUP)
Online
2016-03-24
DOI
10.1093/europace/euw052
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vernakalant-facilitated electrical cardioversion: comparison of intravenous vernakalant and amiodarone for drug-enhanced electrical cardioversion of atrial fibrillation after failed electrical cardioversion
- (2015) Andreas Müssigbrodt et al. EUROPACE
- CardioPulse Articles
- (2015) Laurent Haegeli EUROPEAN HEART JOURNAL
- Propafenone Versus Vernakalant for Conversion of Recent-Onset Atrial Fibrillation
- (2013) Diego Conde et al. Cardiovascular Therapeutics
- Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines
- (2013) I. Savelieva et al. EUROPACE
- Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060
- (2013) B. P. Krijthe et al. EUROPEAN HEART JOURNAL
- Flecainide versus vernakalant for conversion of recent-onset atrial fibrillation
- (2013) Diego Conde et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Rate-Dependent Effects of Vernakalant in the Isolated Non-Remodeled Canine Left Atria Are Primarily Due to Block of the Sodium Channel
- (2012) Alexander Burashnikov et al. Circulation-Arrhythmia and Electrophysiology
- Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial
- (2012) A. J. Camm et al. EUROPACE
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPACE
- A Randomized Active-Controlled Study Comparing the Efficacy and Safety of Vernakalant to Amiodarone in Recent-Onset Atrial Fibrillation
- (2011) A. John Camm et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Vernakalant Hydrochloride: A NovelAtrial-selective Agent for the Cardioversionof Recent-onset Atrial Fibrillation in the Emergency Department
- (2010) Ian G. Stiell et al. ACADEMIC EMERGENCY MEDICINE
- Vernakalant
- (2010) David Tian et al. Cardiology in Review
- Vernakalant Hydrochloride for the Rapid Conversion of Atrial Fibrillation After Cardiac Surgery
- (2009) Peter R. Kowey et al. Circulation-Arrhythmia and Electrophysiology
- Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation
- (2008) Denis Roy et al. CIRCULATION
- Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches
- (2008) I. Savelieva et al. EUROPACE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More